News

Celestica Sets Date for Annual Meeting to Engage Shareholders

Celestica Sets Date for Annual Meeting to Engage Shareholders

Celestica Announces Its Upcoming Annual and Special Shareholder Meeting

Celestica Inc. (TSX: CLS) (NYSE: CLS), a prominent leader in the design, manufacturing, and supply chain solutions, has officially announced its Annual and Special Meeting of Shareholders. This significant event is set to take place on a Tuesday this June at 9:30 a.m. EDT. The hybrid format allows shareholders the flexibility to participate virtually, ensuring broad access to this important meeting.

Key Details About the Meeting

The date for determining eligibility to vote at the Meeting is April 22. This record date ensures that all relevant shareholders are informed and can partake in crucial discussions about the Company’s future. Celestica aims to foster transparency and engagement during these meetings, emphasizing the importance of shareholder participation.

Notice-and-Access Method for Proxy Materials

To streamline communication with its shareholders, Celestica will implement the notice-and-access method. This approach allows for efficient delivery of proxy statements and vital information about the meeting. Shareholders will find the detailed documents that explain how to obtain additional materials available on Celestica’s website as well as regulatory filing systems, underscoring the Company’s commitment to keeping investors well-informed.

Introduction of Advance Notice By-Law

In a move to enhance governance, Celestica has enacted By-Law No. 2, which outlines advance notice requirements for director nominations. This resolution aims to bolster transparency in the nomination process for directors, offering a structured framework that both shareholders and company management can rely on. The new law is designed to allow adequate time for the Company and its shareholders to consider nominations put forth, ensuring clarity in the selection process.

The Purpose of the Advance Notice By-Law

The Advance Notice By-Law is essential for standardizing the nomination deadline and confirming that all necessary information is provided when nominations are submitted. This important policy not only helps streamline the election process but also ensures all potential nominees are thoroughly vetted before any meeting, promoting an informed decision-making environment among shareholders.

About Celestica's Operations and Vision

Celestica is dedicated to empowering innovative brands across various industries. Its expertise spans Aerospace and Defense, Communications, HealthTech, and more, demonstrating the Company’s diverse capabilities and understanding of complex challenges faced by its clients. The synergy between the Company’s design and manufacturing processes fosters rich partnerships that drive cutting-edge solutions tailored to specific client needs.

The Role of Celestica’s Global Teams

With talented professionals across North America, Europe, and Asia, Celestica leverages a truly global perspective. The company thrives on collaboration and innovation, imagining future solutions while effectively executing them in the present. This commitment to excellence facilitates the Company’s goal of delivering reliable products and services that meet the highest standards of quality and efficiency.

Contact Information for Shareholders

Shareholders and interested parties seeking additional information are encouraged to contact the Company directly.

Celestica Global Communications

Phone: (416) 448-2200

Celestica Investor Relations

Phone: (416) 448-2211
Email: media@celestica.com
Email: clsir@celestica.com

Frequently Asked Questions

When will the Annual Meeting of Shareholders occur?

The Annual Meeting is scheduled for June at 9:30 a.m. EDT.

What is the purpose of the Advance Notice By-Law?

This By-Law establishes clear guidelines for the nomination process of directors, ensuring transparency and structure.

How can shareholders access proxy materials?

Celestica will provide proxy materials through a notice-and-access method, available on its official website and filing systems.

What factors contribute to Celestica's strategic advantages?

Celestica's expertise across multiple industries, innovative solutions, and global presence enhance its strategic advantages.

Who should shareholders contact for inquiries?

Shareholders can contact Celestica Global Communications or Investor Relations for further information.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Baidu Faces Class Action: Investors Push Against Fraud Allegations

Updated Category News Views 2

Baidu Under Fire for Alleged Misleading Statements Here's a fresh slice of drama straight outta the corporate trenches: Baidu, Inc. (NASDAQ: BIDU) finds itself tangled in a securities fraud lawsuit that’s causing a ruckus across investor circles. Schall, Brown & Schwartz LLP, those heavyweight gladiators in shareholder rights, are calling on grieved investors to step up...

Continue Reading
Food Trends Tease: 2027 sofi™ Awards' 75 Finalists

Updated Category News Views 1

The Specialty Food Scene Heats Up Today’s world doesn’t rest when it comes to innovation, and the same goes for the tantalizing realm of specialty foods. Hot off the press, the Specialty Food Association (SFA) just rolled out the red carpet for its 75 finalists in the 2027 sofi™ Awards. These are the future taste shapers set to take center stage at the Winter...

Continue Reading
Kenneth Smith Takes Helm for Trends Int’l Expansion

Updated Category News Views 0

Tired of the Same Old Leadership Shuffle? Here Comes Kenneth Smith Look, I’ve seen my share of execs come and go, usually dragging the same old briefcase of stale ideas. But Kenneth Smith stepping up as CEO of Trends International? Now that’s got some real teeth to it. Come May 2026, he’s the guy at the helm, and he's got one hell of a to-do list. Smith's Roadmap: A...

Continue Reading
LINC Lawsuit: Boardroom Stumbles Spark Investor Action

Updated Category News Views 4

Class Action Kickoff: Lincoln's Educational Curveball No one fancies home runs when the ball’s out of sight, and that’s probably how some investors in Lincoln Educational Services Corporation (NASDAQ: LINC) are feeling right now. A group of shareholders has pulled back the curtain on what they believe are more than just administrative hiccups—allegations of...

Continue Reading
Nest Health Appoints Peter Morrison for Multistate Expansion

Updated Category News Views 3

Peter Morrison Steps Up as Chief Growth Officer You know, it's not every day you see a move as gutsy as Nest Health's recent appointment of Peter Morrison. They're shaking up the Medicaid space, aiming to redefine primary care for families with limited resources. Morrison, coming from heavyweights like UnitedHealthcare and Centene, isn't your typical pencil-pusher. He’s...

Continue Reading
Senté’s Heparan Sulfate Pairing: Peer-Reviewed Success

Updated Category News Views 0

Senté's Science-Driven Approach in Skincare Alright, cutting through the skincare noise, Senté Labs has pulled off something impressive—not just another jar of promises but actual, peer-reviewed science backing their Defense C Serum. Published in the Journal of Cosmetic Dermatology, this study isn't just talk about ingredients; it's a show of real results. This isn't...

Continue Reading
GELITA Showcases Collagen Innovations at SupplySide 2026

Updated Category News Views 11

Collagen Solutions Front and Center First up, a little chat about collagen might be in order. For folks not tied into the science side, it sounds like a trendy wellness potion. But here comes GELITA at SupplySide Global 2026, showing it's the real McCoy. Nestled in Booth #4565, they're laying out a spread of next-gen collagen innovations aimed at everything from wound...

Continue Reading
QFIN Faces Class Action: Investors' Role Explored

Updated Category News Views 0

Cracks in the Facade: QFIN's Legal Mess You're cruising down the usual market lanes when—bam!—news breaks that Qfin Holdings, Inc. (NASDAQ: QFIN) finds itself hip-deep in a class action lawsuit. Seems like our pals at Schall, Brown & Schwartz LLP have thrown the gauntlet down, with claims of some serious smoke and mirrors during the March to August stretch of 2026....

Continue Reading
Kansai Medical Ushers in New Era of Cancer Research

Updated Category News Views 6

Breaking Ground in Cancer Treatment Trials I've seen some thrilling breakthroughs in my time following the pharmaceutical industry, but what Kansai Medical University and Daiichi Sankyo are doing elevates the game. They're rolling out the first patient dose of DS1025 in Osaka, Japan—a move that marks the onset of a global Phase 1 clinical trial. This is no ordinary...

Continue Reading
De¹ Unveils Tokenization Model on BNB Chain

Updated Category News Views 2

De¹'s Bold Move into Enhanced Digital Finance Just when you thought the financial landscape couldn’t get any more complex, De¹ steps into the ring with its Tokenized Asset World on the BNB Chain—a move that's stirring the pot of tokenized finance in more ways than one. For old-school investors who thrive on waving outlandish stock bets, this crypto narrative is a...

Continue Reading

Top 5 Most Recently Viewed Articles

Blackline Safety Posts 27% Revenue Surge in Fiscal Year 2024

Updated Category News Views 434

Blackline Safety's Fiscal Year 2024 Financial Performance Blackline Safety Corp. (TSX: BLN) has made impressive strides in its financial outcomes for the recent fiscal year. The company reports a remarkable total revenue of $127.3 million for 2024, marking a significant 27% increase year-over-year. These results demonstrate the effectiveness of the company's strategic...

Continue Reading
Government Projects India's Economic Growth at 6.5% for FY25

Updated Category News Views 237

Economic Growth Projections for India in FY25 The Indian economy is set to grow at an estimated rate of 6.5% during the fiscal year 2024/25. This projection, provided by government officials, aligns closely with the lower end of a broader range set between 6.5% and 7%. This outlook is framed against a backdrop of global uncertainties that could impact domestic growth...

Continue Reading
Investors Urged to Act on NANO Nuclear Energy Fraud Claims

Updated Category News Views 75

Overview of NANO Nuclear Energy NANO Nuclear Energy Inc. has recently found itself in the news due to a securities fraud lawsuit filed against the company. This situation serves as a crucial reminder for investors to actively seek information about their rights and options for potential recovery. Lawsuit Details The case, referred to as Yang v. Nano Nuclear Energy, Inc.,...

Continue Reading
Westinghouse Air Brake Technologies: A Potential Rebound Ahead

Updated Category News Views 127

Understanding Westinghouse's Current Position Shares of Westinghouse Air Brake Technologies Corporation (WAB) recently faced significant declines following disappointing earnings reports. However, the stock now appears to be positioned for a possible rally. Oversold Conditions and Key Support Levels The latest performance indicates that shares have become oversold,...

Continue Reading
BrainStorm Announces New Date for First Quarter Financial Call

Updated Category News Views 261

BrainStorm Reschedules Q1 2025 Financial Results Release BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a pioneer in adult stem cell therapeutics for neurodegenerative diseases, recently announced an important update regarding its financial results. The company has moved the release date for its financial performance for the first quarter, which ended on March 31,...

Continue Reading